Navifus Corporation
Clinical trials sponsored by Navifus Corporation, explained in plain language.
-
Sound waves against seizures: new device tested for Drug-Resistant epilepsy
Disease control Recruiting nowThis pilot study tests a device called NaviFUS that uses low-intensity focused ultrasound to calm overactive brain areas. It involves 16 adults with drug-resistant epilepsy who still have frequent seizures despite trying at least three medications. The goal is to see if the treat…
Phase: NA • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Sound waves open brain barrier to attack deadly tumor
Disease control Recruiting nowThis early study tests a combination approach for recurrent glioblastoma, an aggressive brain cancer. The treatment uses focused ultrasound (NaviFUS) to temporarily open the blood-brain barrier, allowing the drug Avastin (bevacizumab) to reach the tumor more effectively. Ten adul…
Phase: PHASE1, PHASE2 • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Sound waves could boost brain cancer drug delivery
Disease control Recruiting nowThis Phase 3 trial tests whether combining the drug Avastin with a focused ultrasound system (NaviFUS) can improve outcomes for people with recurrent glioblastoma, an aggressive brain cancer. The ultrasound temporarily opens the blood-brain barrier to let more drug reach the tumo…
Phase: PHASE3 • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Sound waves aimed at the brain could tame seizures
Symptom relief Recruiting nowThis early study tests a device that uses low-intensity focused ultrasound to calm overactive brain areas in people with drug-resistant temporal lobe epilepsy. Eight adults will receive up to three 10-minute ultrasound sessions. Researchers will track side effects and check if se…
Phase: PHASE1, PHASE2 • Sponsor: NaviFUS Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC